Screening for urinary tract infection with the Mastascan Elite

Area of Science:

• Clinical Microbiology
• Diagnostic Technology
• Infectious Diseases

Background:

• Urinary tract infections (UTIs) are common, requiring accurate and rapid pathogen identification and antibiotic susceptibility testing.
• Conventional urine culture methods can be time-consuming, delaying appropriate treatment.
• The Mastascan Elite urine screen (MUS) is a novel system designed to expedite these processes.

Purpose of the Study:

• To evaluate the performance of the Mastascan Elite urine screen (MUS) against a conventional method for detecting significant bacteriuria.
• To assess the accuracy of MUS in pathogen identification and antibiotic susceptibility determination directly from urine samples.
• To compare the efficiency and resource utilization of MUS versus traditional methods.

Main Methods:

• A comparative study was conducted using the Mastascan Elite urine screen (MUS) and a conventional urine culture method.
• The sensitivity and specificity of MUS were determined for detecting bacterial growth (≥10^3 cfu/mL).
• Accuracy in pathogen identification and antibiotic susceptibility testing was assessed, along with turnaround times.

Main Results:

• MUS demonstrated high accuracy, with 161 true positives (15.2%) and 840 true negatives (79.2%).
• Overall performance for antibiotic susceptibility testing showed 82.4% true susceptibility and 10.5% true resistance.
• MUS provided results in 24 hours for 94.7% of samples, significantly faster than the conventional method (78.4%).

Conclusions:

• The Mastascan Elite urine screen (MUS) is an effective and efficient method for processing urine samples.
• MUS significantly reduces turnaround time for urine culture results, saving time, materials, and human resources.
• This technology offers a valuable alternative for rapid UTI diagnosis and management.